Patent · US Expired

Vaccine composition containing polyribosylribitol phosphate and method for making same

US6333036A · kind A · utility

8Cited by

1References

11Claims

0Family size

Assignee

Pasteur Mérieux Sérums et Vaccins S.A. · FR

Inventors

Francois Arminjon · Val-de-Reuil, FR
Jean-Rene Cartier · Val-de-Reuil, FR

Key dates

Filing date	Dec 30, 1997
Grant date	Dec 25, 2001
Priority date	—
Expiry date	Dec 30, 2017

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S424/831
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Vaccine compositions are disclosed which comprise at least one antigen formed by the capsular polysaccharide of Haemophilus influenzae type b or high molecular weight polyribosylribitol phosphate coupled to tetanus anatoxin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.